236 related articles for article (PubMed ID: 33042133)
1. STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity.
Meissl K; Simonović N; Amenitsch L; Witalisz-Siepracka A; Klein K; Lassnig C; Puga A; Vogl C; Poelzl A; Bosmann M; Dohnal A; Sexl V; Müller M; Strobl B
Front Immunol; 2020; 11():2189. PubMed ID: 33042133
[TBL] [Abstract][Full Text] [Related]
2. STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity.
Semper C; Leitner NR; Lassnig C; Parrini M; Mahlakõiv T; Rammerstorfer M; Lorenz K; Rigler D; Müller S; Kolbe T; Vogl C; Rülicke T; Staeheli P; Decker T; Müller M; Strobl B
Mol Cell Biol; 2014 Jun; 34(12):2235-48. PubMed ID: 24710278
[TBL] [Abstract][Full Text] [Related]
3. Distinct requirements for IFNs and STAT1 in NK cell function.
Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
[TBL] [Abstract][Full Text] [Related]
4. Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation.
Robbins SH; Tessmer MS; Van Kaer L; Brossay L
Eur J Immunol; 2005 Mar; 35(3):757-65. PubMed ID: 15719366
[TBL] [Abstract][Full Text] [Related]
5. The C-Terminal Transactivation Domain of STAT1 Has a Gene-Specific Role in Transactivation and Cofactor Recruitment.
Parrini M; Meissl K; Ola MJ; Lederer T; Puga A; Wienerroither S; Kovarik P; Decker T; Müller M; Strobl B
Front Immunol; 2018; 9():2879. PubMed ID: 30574148
[TBL] [Abstract][Full Text] [Related]
6. STAT1β enhances STAT1 function by protecting STAT1α from degradation in esophageal squamous cell carcinoma.
Zhang Y; Chen Y; Yun H; Liu Z; Su M; Lai R
Cell Death Dis; 2017 Oct; 8(10):e3077. PubMed ID: 28981100
[TBL] [Abstract][Full Text] [Related]
7. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
[TBL] [Abstract][Full Text] [Related]
8. The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15/IL-15Rα treatment.
Nair S; Fang M; Sigal LJ
Aging Cell; 2015 Apr; 14(2):180-90. PubMed ID: 25399821
[TBL] [Abstract][Full Text] [Related]
9. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
10. NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity.
Simonović N; Witalisz-Siepracka A; Meissl K; Lassnig C; Reichart U; Kolbe T; Farlik M; Bock C; Sexl V; Müller M; Strobl B
J Immunol; 2019 Mar; 202(6):1724-1734. PubMed ID: 30718299
[TBL] [Abstract][Full Text] [Related]
11. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
12. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
[TBL] [Abstract][Full Text] [Related]
13. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
14. Modulation of antitumour immune responses by intratumoural Stat1 expression.
Messina NL; Banks KM; Vidacs E; Martin BP; Long F; Christiansen AJ; Smyth MJ; Clarke CJ; Johnstone RW
Immunol Cell Biol; 2013 Oct; 91(9):556-67. PubMed ID: 23958683
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
Zhang C; Zhang J; Niu J; Zhang J; Tian Z
Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
[TBL] [Abstract][Full Text] [Related]
16. Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15.
Zhang F; Little A; Zhang H
J Leukoc Biol; 2017 Apr; 101(4):1015-1027. PubMed ID: 27837016
[TBL] [Abstract][Full Text] [Related]
17. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.
Huntington ND; Legrand N; Alves NL; Jaron B; Weijer K; Plet A; Corcuff E; Mortier E; Jacques Y; Spits H; Di Santo JP
J Exp Med; 2009 Jan; 206(1):25-34. PubMed ID: 19103877
[TBL] [Abstract][Full Text] [Related]
18. Cardif (MAVS) Regulates the Maturation of NK Cells.
Haynes LD; Verma S; McDonald B; Wu R; Tacke R; Nowyhed HN; Ekstein J; Feuvrier A; Benedict CA; Hedrick CC
J Immunol; 2015 Sep; 195(5):2157-67. PubMed ID: 26232430
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium avium inhibition of IFN-gamma signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1 beta by mRNA stabilization.
Alvarez GR; Zwilling BS; Lafuse WP
J Immunol; 2003 Dec; 171(12):6766-73. PubMed ID: 14662881
[TBL] [Abstract][Full Text] [Related]
20. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
